SEARCH
Search Details
YAKUSHIJIN Kimikazu
Research activity information
■ Award■ Paper
- Sinusoidal obstruction syndrome (SOS) is a lethal complication after hematopoietic stem cell transplantation (HSCT). Defibrotide (DF) is the only drug internationally recommended for SOS treatment in Western countries. Recombinant human soluble thrombomodulin (rhTM), which is promising for the treatment of patients with disseminated intravascular coagulation, is also reported to be potentially effective for SOS. To clarify the safety and efficacy of DF and rhTM, we conducted a retrospective survey of these agents in Japan. Data from 65 patients who underwent allogeneic HSCT and received DF (n = 24) or rhTM (n = 41) for SOS treatment were collected. The complete response rates for SOS on day 100 were 50% and 54% in the DF and rhTM groups, respectively. The 100-day overall survival rates were 50% in the DF group, and 48% in the rhTM group. Several severe hemorrhagic adverse events were observed in one patient in the DF group and five patients in the rhTM group. The main causes of death were SOS-related death, and no patient died of direct adverse events of DF or rhTM. Our results suggest that rhTM, as well as DF, can be effective as a novel treatment option for SOS.May 2019, Bone marrow transplantation, 54(5) (5), 674 - 680, English, International magazine[Refereed]Scientific journal
- Chemotherapy-induced peripheral neuropathy (CIPN) frequently occurs in lymphoma patients receiving R-CHOP, a drug combination therapy. Although severe CIPN may lead to reduction and/or discontinuation of the medication, predictive factors of CIPN have not been investigated sufficiently to date. We performed a retrospective exploratory research to determine associations between prevalence of severe CIPN and sociodemographic data, health characteristics, and medical conditions such as anemia at initial diagnosis. Forty patients (indolent lymphoma, n = 9; diffuse large B-cell lymphoma; n = 31) received R-CHOP therapy from September 2009 to July 2014. The median age of patients was 58 years (range = 27-76 years). Statistical analyses were applied to the patients, who were divided into two groups: mild CIPN (no symptoms or grade 1 according to the CTCAE version 3.0 program) and severe CIPN patients (grade 2 or higher). Forward stepwise logistic regression analyses were performed using the following variables: sex, BMI, BSA, hyperglycemia, malnutrition, and anemia. Severe CIPN occurred in seven patients (17.5%). Gender and anemia remained following the stepwise procedure, and anemia predicted severe CIPN significantly (OR = 19.45, 95% confidence interval = 1.52-171.12). Our study suggests that anemia at initial diagnosis could be a predictive factor of R-CHOP-induced CIPN.Mar. 2019, Oncology research, 27(4) (4), 469 - 474, English, International magazine[Refereed]Scientific journal
- A 45-year-old woman was diagnosed with hepatosplenic T-cell lymphoma (HSTCL), a rare subtype of peripheral T-cell lymphoma. She received different types of chemotherapy, but disease progression was observed. To reduce the tumor burden before an unrelated bone marrow transplantation, combination chemotherapy consisting of the gemcitabine, carboplatin, and dexamethasone (GCD) was administered as bridging therapy, resulting in a reduction in the number of lymphoma cells. We were then able to perform bone marrow transplantation. Although she experienced some adverse events, she successfully achieved long-term remission. We herein report a successful case of HSTCL treated with unrelated stem cell transplantation following the GCD regimen as bridging chemotherapy.Mar. 2019, Intern Med., 58(5) (5), 707 - 712, English, Domestic magazine[Refereed]Scientific journal
- BACKGROUND: Human herpesvirus 6 (HHV-6) encephalitis is a known life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, few studies have focused on the occurrence of HHV-6 encephalitis in patients receiving mycophenolate mofetil (MMF) combined with a calcineurin inhibitor as prophylaxis for graft-versus-host disease (GVHD). This study aimed to investigate the impact of MMF administered for GVHD prophylaxis in the occurrence of HHV-6 encephalitis after allo-HSCT and the characteristics of this condition. METHODS AND RESULTS: We retrospectively analyzed 73 patients who underwent allo-HSCT (83 transplants) at our hospital between April 2010 and December 2015. MMF (2-3 g/d) was administered along with a calcineurin inhibitor. Seven patients (8.0%) developed encephalitis due to HHV-6. The median period from allo-HSCT to the onset of HHV-6 encephalitis was 23 days (range, 17-98 days). The cumulative incidence of HHV-6 encephalitis on day 100 after treatment was 12% and 6% in patients who underwent cord blood transplantation (CBT) and non-CBT (ie, bone marrow transplantation and peripheral blood stem cell transplantation), respectively (P = 0.344). Neurological symptoms of encephalitis were more severe in non-CBT cases than those in CBT cases. All patients diagnosed with HHV-6 encephalitis were treated with ganciclovir or foscarnet. None of the enrolled patients died from HHV-6 encephalitis. CONCLUSIONS: Mycophenolate mofetil may have the potential to increase the frequency of severe HHV-6 encephalitis in patients undergoing CBT and non-CBT. Thus, MMF should be administered with caution, and patients should be monitored closely for HHV-6 encephalitis even those who did not undergo CBT.Feb. 2019, Transpl Infect Dis., 21(1) (1), e13024, English, International magazine[Refereed]Scientific journal
- Scopulariopsis alboflavescens is a soil saprophyte that is widely distributed in nature. Recently, there have been increasing number of reports of invasive infections with Scopulariopsis species in immunocompromised patients. In this report, we described an adult woman with acute myeloid leukemia and who developed S. alboflavescens pneumonia. Liposomal amphotericin B and voriconazole combination therapy was unsuccessful and the patient died because of pneumonia. Scopulariopsis is highly resistant to available antifungal agents and almost invariably fatal. This case report should alert clinicians to the importance of listing Scopulariopsis as a pathogenic fungus in immunocompromised patients.Dec. 2018, Int J Hematol., 108(6) (6), 658 - 664, English, Domestic magazine[Refereed]Scientific journal
- A 69-year-old woman who had been diagnosed with unresectable papillary thyroid cancer was referred to our hospital. We initially treated her with sorafenib, but she subsequently developed erythema multiforme, which was suspected to be a drug rush due to sorafenib; therefore, sorafenib was discontinued. At the time of discontinuation, immature blast cells were detected in her peripheral blood. Approximately two weeks later, her skin rash improved substantially, but the proportion of blasts in the peripheral blood increased. We performed a bone marrow examination, and she was diagnosed with FLT3-ITD-positive acute myeloid leukemia. FLT3-ITD expression is found in 20-25% of AML and is a known independent poor prognostic factor. To overcome the poor prognosis associated with FLT3-ITD, molecular drugs targeting FLT3-ITD are attracting much attention. Sorafenib, a multi-kinase inhibitor, also has an effect on FLT3-ITD. Although primary disease flares after tyrosine kinase inhibitor discontinuation have been reported, this is the first report to describe discontinuation of sorafenib treatment as a potential trigger of FLT3-ITD-positive acute myeloid leukemia in papillary thyroid cancer.Dec. 2018, J Oncol Pharm Pract, 25(8) (8), 2010 - 2015, English, International magazine[Refereed]Scientific journal
- PURPOSE: The purpose of this study was to measure the frequency and identify factors associated with delayed socket healing after dental extraction in patients undergoing myelosuppressive chemotherapy for hematologic malignancy. MATERIALS AND METHODS: This prospective cohort study focused on delayed healing after extraction in patients with hematologic malignancy. Sockets with delayed healing were defined as those with intense pain and bone exposure 1 week postoperatively. Patients with and without delayed socket healing were compared using the Fisher exact test and Mann-Whitney U test with some variables. Receiver operating characteristics curve analysis was conducted to define cutoff values for delayed healing. RESULTS: One hundred ninety-four dental extractions in 93 patients (median age, 64 yr; range, 20 to 85 yr) were analyzed. The incidence of delayed socket healing was 7.5% (7 of 93 patients). There was no postoperative bleeding. Older age, type of hematologic malignancy (acute leukemia), shorter time from dental extraction to initiation of chemotherapy, low platelet count or hemoglobin level, requirement for red blood cell concentrate or platelet transfusion, and use of an absorbable hemostatic agent were statistically associated with the occurrence of delayed socket healing. Platelet and hemoglobin cutoffs were 4.6 × 104/μL and 7.7 g/dL, respectively. CONCLUSIONS: Although dental extraction can be safely performed in patients undergoing myelosuppressive chemotherapy for hematologic malignancy, oral surgeons should understand the potential risk for delayed socket healing. When considering dental extraction, patients with hematologic malignancy and low hemoglobin or platelet levels should be informed about the possibility of delayed socket healing.Oct. 2018, J Oral Maxillofac Surg, 76(10) (10), 2057 - 2065, English, International magazine[Refereed]Scientific journal
- BACKGROUND: CD134 (OX40), which is a cellular receptor for human herpesvirus-6B (HHV-6B) and expresses on activated T cells, may play a key role for HHV-6B replication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). OBJECTIVES: Therefore, we examined the CD134 expression on T cells and HHV-6B replication after allo-HSCT, and analyzed the correlation between them. STUDY DESIGN: Twenty-three patients after allo-HSCT were enrolled. The percentages of CD134-positive cells within the CD4+ and CD8+ cell populations were measured by flow cytometry, and the viral copy number of HHV-6B was simultaneously quantified by real-time PCR. The correlation between CD134 and HHV-6B viral load was then statistically analyzed. RESULTS: HHV-6B reactivation occurred in 11 of 23 patients (47.8%). CD134 expression was seen on T cells and was coincident with the time of peak viral load. The percentage of CD134-positive cells decreased significantly when HHV-6B DNA disappeared (p = .005 in CD4+ T cells, p = .02 in CD8+ T cells). In the 4 patients who underwent umbilical cord blood transplantation (UCBT), the viral load varied with the percentage of CD134-positive cells. In the comparison between the HHV-6B reactivation group and non-reactivation group, maximum percentages of CD134-positive cells among CD4+ T cells in reactivation group were significantly higher than those in non-reactivation group (p = .04). CONCLUSIONS: This is the first study to show that a correlation of CD134 expression on T cells with HHV-6B replication after allo-HSCT, especially in UCBT. The results possibly indicate that CD134 on T cells plays a key role for HHV-6B replication after allo-HSCT.May 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 102, 50 - 55, English, International magazine[Refereed]Scientific journal
- PURPOSE: Mycophenolate mofetil (MMF) is increasingly used among Japanese patients undergoing allogeneic hematopoietic stem cell transplantation (allo-SCT). Because pharmacokinetic data for MMF in the Asian population are limited, we conducted this investigation. METHODS: Intravenous MMF (1000 mg/dose) was administered to 10 patients along with cyclosporine or tacrolimus for 10 days after allo-SCT; it was administered every 8 h in peripheral blood stem cell- and bone marrow-transplanted patients, and every 12 h in cord blood-transplanted patients. MMF was administered orally at the same dose from day 11. Plasma concentrations of mycophenolic acid (MPA) were measured by high-performance liquid chromatography. RESULTS: The MPA AUC0 - tau was 31.9 ± 3.4, 26.2 ± 2.4, and 21.0 ± 2.2 µg*h/mL, the mean Ctrough was 0.25, 0.35, and 0.37 µg/mL, and the Cmax was 10.8, 9.2, and 5.5 µg/mL on days 2, 9, and 16, respectively. The AUC0 - tau and Cmax were significantly higher after intravenous MMF dosing than after oral MMF dosing. All patients exhibited successful neutrophil engraftments in a median time of 18 days. Grade II acute graft-versus-host disease (GvHD) of the skin was observed in two patients, and one patient developed limited chronic GvHD. Individual cases of transient and curable grade III oral mucositis and diarrhea were observed; however, MMF was not discontinued. No other severe complications or infections were observed. CONCLUSIONS: Intravenously administered MMF was safe and possibly effective in achieving higher MPA plasma concentrations for GvHD prophylaxis after allo-SCT in Japanese patients.Mar. 2018, Cancer Chemother Pharmacol, 81(5) (5), 839 - 846, English, International magazine[Refereed]Scientific journal
- Lymph node infarction is very rare, and is frequently associated with neoplasms, such as malignant lymphoma and non-neoplastic disease, or interventions such as fine-needle aspiration (FNA). A 76-year-old-man presented with cervical lymph node swelling. Although FNA was performed, the findings were insufficient for a definitive diagnosis. Consequently, surgical biopsy of the cervical lymph node was performed, which revealed total infarction; a diagnosis of classical Hodgkin lymphoma was made later. Both lymphoma itself and FNA may cause total lymph node infarction, which makes diagnosis confusing. Therefore, it is important to repeat the biopsy rather than repeat FNA to correctly diagnose malignant lymphoma, including Hodgkin lymphoma.Mar. 2018, J Clin Exp Hematop., 58(1) (1), 24 - 26, English, Domestic magazine[Refereed]Scientific journal
- S. Karger AG, Feb. 2018, Cytogenetic and Genome Research, 153(3) (3), 131 - 137, English[Refereed]Scientific journal
- Springer Tokyo, Jan. 2018, International Journal of Hematology, 107(1) (1), 83 - 91, English[Refereed]Scientific journal
- Dec. 2017, Int J Hematol., 106(6) (6), 729 - 731, EnglishMegakaryoblastic transformation of therapy-related myeloid neoplasms with concomitant MYC amplification on double minute chromosomes.[Refereed]Scientific journal
- Nov. 2017, Clin Nutr, EnglishA multi-center prospective study randomizing the use of fat emulsion in intensive glucose control after allogeneic hematopoietic stem cell transplantation using a myeloablative conditioning regimen[Refereed]Scientific journal
- Jul. 2017, PLoS One, 12(7) (7), e0182021, EnglishIntensity and duration of neutropenia relates to the development of oral mucositis but not odontogenic infection during chemotherapy for hematological malignancy[Refereed]Scientific journal
- Apr. 2017, Int J Hematol, 105(4) (4), 485 - 496, English[Refereed]Scientific journal
- MDPI AG, Mar. 2017, International Journal of Molecular Sciences, 18(3) (3), English[Refereed]Scientific journal
- Feb. 2017, Am J Hematol, 92(2) (2), 171 - 178, EnglishImpact of total body irradiation on successful neutrophil engraftment in unrelated bone marrow or cord blood transplantation[Refereed]Scientific journal
- Feb. 2017, Int J Hematol, 105(2) (2), 226 - 229, EnglishConstitutional t(8;22)(q24;q11.2) that mimics the variant Burkitt-type translocation in Philadelphia chromosome-positive chronic myeloid leukemia[Refereed]Scientific journal
- Dec. 2016, Int J Hematol, 104(6) (6), 682 - 691, EnglishA prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen[Refereed]Scientific journal
- Mar. 2016, Bone Marrow Transplant, 51(3) (3), 403 - 9, EnglishSinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes[Refereed]Scientific journal
- 2016, CYTOGENETIC AND GENOME RESEARCH, 149(3) (3), 165 - 170, English[Refereed]Scientific journal
- Oxford University Press, 2016, Japanese Journal of Clinical Oncology, 46(5) (5), 448 - 452, English[Refereed]Scientific journal
- Dec. 2015, Int J Hematol, 102(6) (6), 713 - 8, EnglishA new transcriptional variant and small azurophilic granules in an acute promyelocytic leukemia case with NPM1/RARA fusion gene[Refereed]Scientific journal
- Springer-Verlag Tokyo, May 2015, International Journal of Hematology, 101(5) (5), 423 - 425, EnglishResearch society
- Feb. 2015, J Dent Res, 94(2) (2), 289 - 96, EnglishProspective study of dental intervention for hematopoietic malignancy[Refereed]Scientific journal
- Feb. 2015, Leuk Lymphoma, 26(1) (1), 1 - 30, EnglishMethotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal[Refereed]Scientific journal
- 2015, Acta Haematol, 134(2) (2), 76 - 9, EnglishTranslocation t(11;19)(q23;q13.1) without MLL Rearrangement in Acute Myeloid Leukemia: Heterogeneity of the 11q23 Breakpoints[Refereed]Scientific journal
- Jan. 2015, Bone Marrow Transplant, 50(1) (1), 100 - 5, EnglishSevere weight loss in 3 months after allogeneic hematopoietic SCT was associated with an increased risk of subsequent non-relapse mortality[Refereed]Scientific journal
- Jan. 2015, Ann Hematol, 94(1) (1), 177 - 9, EnglishConversion from nuclear bilobation to indentation in BCR/ABL1-positive acute myeloid leukemia lacking CD34 and HLA-DR expression[Refereed]Scientific journal
- Mar. 2014, ANNALS OF HEMATOLOGY, 93(3) (3), 499 - 500, English[Refereed]Scientific journal
- Feb. 2014, Ann Hematol, 93(10) (10), 1791 - 3, English, International magazine[Refereed]Scientific journal
- 2014, Acta Haematol, 132(2) (2), 244 - 6, EnglishUnbalanced translocation der(7)t(7q;11q): a new recurrent aberration leading to partial monosomy 7q and trisomy 11q in acute myeloid leukemia[Refereed]Scientific journal
- 2014, J Clin Exp Hematop, 54(2) (2), 167 - 70, English, Domestic magazineA new complex translocation t(8;11;21)(q22;q24;q22) in acute myeloid leukemia with RUNX1/RUNX1T1[Refereed]Scientific journal
- Dec. 2013, Annals of Hematology, 92(12) (12), 1713 - 1715, English[Refereed]Scientific journal
- Dec. 2013, Ann Hematol, EnglishExtramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2)[Refereed]Scientific journal
- Nov. 2013, International Journal of Hematology, 98(5) (5), 608 - 614, English[Refereed]Scientific journal
- Nov. 2013, International Journal of Hematology, 98(5) (5), 513 - 514, English[Refereed]Scientific journal
- Sep. 2013, Bone Marrow Transplantation, 48(9) (9), 1198 - 1204, English[Refereed]Scientific journal
- Aug. 2013, BMC Oral Health, 13(1) (1), 41, English[Refereed]Scientific journal
- Aug. 2013, American Journal of Hematology, 88(8) (8), 717 - 718, English[Refereed]Scientific journal
- Jul. 2013, Int J Hematol, 98(1) (1), 6 - 7, EnglishL-Asparaginase-induced fulminating liver dysfunction[Refereed]Scientific journal
- The impact of hepatitis C virus (HCV) infection on outcomes following allogeneic hematopoietic cell transplantation (HCT) remains a matter of debate. We have retrospectively examined the significance of HCV infection among recipients who received allogeneic HCT, using a Japan transplant outcome registry database between 2006 and 2009. Among 7,831 recipients, 136 were HCV-positive. The rate of hematopoietic recovery was lower in the HCV-positive group (neutrophil recovery of 500 × 10(6) /L or higher: 79% vs. 87% at Day 30, P = 0.087; platelet recovery of 50 × 10(9) /L or higher: 57% vs. 65% at Day 60, P = 0.012). The HCV-positive group had a significantly higher incidence of nonrelapse mortality 38% vs. 25% at 2 years, P < 0.01) and inferior overall survival (41% vs. 51% at 2 years, P < 0.01). A multivariate analysis revealed that HCV seropositivity was associated with an independent risk for higher nonrelapse mortality (hazard ratio: 1.65, P < 0.01) and inferior overall survival (hazard ratio: 1.39, P < 0.01). The incidences of death due to hepatic problems (8% vs. 2%, P < 0.01), bacterial infection (10% vs. 4%, P < 0.01), or graft failure (5% vs. 2%, P = 0.084) tended to be higher in the HCV-positive group. HCV infection had an adverse impact on the clinical outcome following HCT, especially in the setting of unrelated transplantation. Careful evaluation before embarking on HCT and intensive assessment against complications are warranted in HCV-infected recipients.Jun. 2013, American journal of hematology, 88(6) (6), 477 - 84, English, International magazine[Refereed]Scientific journal
- Apr. 2013, 日本リンパ網内系学会会誌, 53, 109, Japanese骨髄原発B細胞リンパ腫において新規に見つかったMYCとBCL6の改変を伴った5ヶ所の転座 t(3;9;13;8;14)(q27;p13;q32;q24;q32)(A novel five-way translocation, t (3:9:13:8:14) (q27:p13:q32:q24:q32), with concurrent MYC and BCL6 rearrangements in primary bone marrow B-cell lymphoma)(英語)Research society
- Apr. 2013, Bone Marrow Transplant, 48(4) (4), 529 - 36, EnglishChanges in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry[Refereed]Scientific journal
- Mar. 2013, Ann Hematol, 92(3) (3), 403 - 5, EnglishPericentric chromosome 8 inversion, inv8(p11.2q22), associated with RUNX1/RUNX1T1 rearrangement in acute myeloid leukemia[Refereed]Scientific journal
- Feb. 2013, 日本医学放射線学会学術集会抄録集, (72回) (72回), S402, Japanese鼻腔原発NK/T細胞リンパ腫に対する放射線治療経験[Refereed]Research society
- Feb. 2013, Int J Hematol, 97(2) (2), 284 - 6, EnglishTolvaptan as an alternative treatment for refractory fluid retention associated with sinusoidal obstruction syndrome after allogeneic stem cell transplantation[Refereed]Scientific journal
- Gain of 11q by an additional ring chromosome 11 and trisomy 18 in CD5-positive intravascular large B-cell lymphomaChromosomal abnormalities of intravascular large B-cell lymphoma (IVLBCL), a rare form of extranodal diffuse large B-cell lymphoma, have been described in only a small number of cases. A 59-year-old female presented with pancytopenia and splenomegaly. Bone marrow was normocellular with 30.4% abnormal large lymphoid cells that were positive for CD5, CD19, CD20, HLA-DR and λ chain. Bone marrow biopsy showed intrasinusoidal infiltration of large lymphoid cells. G-banding and spectral karyotyping of the bone marrow cells demonstrated a complex karyotype as follows : 48,XX,-8,+r(11),+12,del(12)(p?) ×2,+18,der(19)(19?::p13 → qter),der(21)t(8;21)(q11.2;p11.2). Fluorescence in situ hybridization on interphase nuclei revealed three signals of CCND1 at 11q13, but two signals of BIRC3 at 11q22 and MLL at 11q23, indicating that r(11) contained CCND1. Together with other reported cases, our results indicate that the gain of 11q as well as trisomy 18 may be among the recurrent chromosomal aberrations in IVLBCL. Furthermore, an additional ring chromosome 11 could be a novel mechanism leading to the gain of 11q.2013, J Clin Exp Hematop, 53(2) (2), 161 - 5, English, Domestic magazine[Refereed]Scientific journal
- Jan. 2013, Leuk Lymphoma, 0001(01) (01), 1 - 2, EnglishHyperdiploidy and duplication of der(11)ins(10;11)(p12;q23q14) in acute myeloid leukemia with MLL/MLLT10 fusion gene[Refereed]Scientific journal
- Jan. 2013, Eur J Haematol, 90(1) (1), 68 - 75, EnglishA novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34)[Refereed]Scientific journal
- Dec. 2012, Leuk Res, 36(12) (12), e218 - 21, EnglishIGH@/BCL6 rearrangement on the der(3)t(3;14)(q27;q32) in primary mediastinal large B-cell lymphoma[Refereed]Scientific journal
- 日本皮膚アレルギー・接触皮膚炎学会, Oct. 2012, Journal of Environmental Dermatology and Cutaneous Allergology, 6(5号) (5号), 433 - 438, Japanese多彩な神経症状を呈し、再燃時に皮疹を認めたジアフェニルスルホンによるDIHSの1例[Refereed]Scientific journal
- Aug. 2012, Am J Hematol, 87(8) (8), 770 - 5, EnglishComparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma[Refereed]Scientific journal
- Jun. 2012, European journal of haematology, Vol. 88, No. 6, pp. 553-4, EnglishReed-Sternberg-like cells of ALK-positive anaplastic large cell lymphoma with near-tetraploidyScientific journal
- Apr. 2012, Leukemia research, Vol. 36, No. 4, pp. e84-6, EnglishA novel recurrent translocation t(7;17)(q22;p13) and a late-appearing t(2;3)(p13;q26.2) with dysmegakaryopoiesis in acute myeloid leukemiaScientific journal
- Mar. 2012, European journal of haematology, Vol. 88, No. 3, pp. 244-248, EnglishExpression of the novel NUP98/PSIP1 fusion transcripts in myelodysplastic syndrome with t(9;11)(p22;p15)Scientific journal
- Jan. 2012, 臨床血液, 53巻, 1号, pp. 118-119, JapaneseSMILE療法及び同種骨髄移植によって良好な経過が得られた再発・難治性NK/T細胞リンパ腫の1例International conference proceedings
- Nov. 2011, Leukemia research, Vol. 35, No. 11, pp. e212-4, EnglishBiallelic ETV6 rearrangements by recurrent translocations t(7;12)(p15;p13) and t(3;12)(q26.2;p13) in acute myeloid leukemiaScientific journal
- Sep. 2011, Cancer genetics, Vol. 204, No. 9, pp. 501-6, EnglishA novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma[Refereed]Scientific journal
- Jul. 2011, Journal of Environmental Dermatology and Cutaneous Allergology, 5巻, 3号, pp. 263-263, Japanese皮疹を欠くもののHHV-6の再活性化と多彩な臓器症状を呈したレクチゾールによるDrug hypersensitivityの1例International conference proceedings
- Jun. 2011, International journal of hematology, 93(6) (6), 765 - 70, EnglishSuccessful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis[Refereed]Scientific journal
- Jun. 2011, 日本検査血液学会雑誌, 12巻, 学術集会, pp. S79-S79, JapaneseNPM/RARαキメラ遺伝子を認めた急性前骨髄性白血病の一例International conference proceedings
- Jun. 2011, Biology of blood and marrow transplantation, Vol. 17, No. 6, pp. 841-51, EnglishFeasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patientsScientific journal
- Mar. 2011, Leuk Res, EnglishA novel dicentric chromosome, dic(9;9)(p12;q34), leading to trisomy 9 in follicular lymphoma without t(14;18)[Refereed]Scientific journal
- 2011, Internal medicine (Tokyo, Japan), Vol. 50, No. 24, pp. 3031-5, EnglishTherapy-related pure erythroid leukemia with hepatic infiltration and hemophagocytic syndrome[Refereed]Scientific journal
- 2011, Internal medicine (Tokyo, Japan), Vol. 50, No. 8, pp. 941-941, EnglishFungal endophthalmitis successfully treated with intravitreal voriconazole injection[Refereed]Scientific journal
- May 2019, Leukemia & lymphoma, 60(5) (5), 1294 - 1298, English, International magazine[Refereed]Report scientific journal
- Mar. 2019, 消化器・肝臓内科, 5(3) (3), 356 - 364, Japanese【薬物性肝障害:新薬登場で変わる実態】 造血幹細胞移植とSOS/VOD[Invited]Introduction commerce magazine
- Nov. 2018, Leukemia & lymphoma, 59(11) (11), 2706 - 2710, English, International magazine[Refereed]Report scientific journal
- Nov. 2016, Int J Hematol, 104(5) (5), 531 - 533, EnglishSea-blue histiocytes in acute myeloid leukemia with trisomy 9[Refereed]Report scientific journal
- Sinusoidal obstruction syndrome (SOS), also called veno-occlusive disease (VOD) of the liver, is one of the most relevant complications of hepatic sinusoidal endothelial origin that appears early after haematopoietic cell transplantation (HCT). Despite its relatively low incidence and the fact that most cases of SOS/VOD resolve spontaneously, in the severe SOS/VOD that evolve to multi-organ failure have a mortality rate higher than 80% and represent one of the major clinical problems after HCT. In these patients, the sinusoidal endothelial cells and hepatocytes are damaged by toxic metabolites generated by the conditioning regimen. Several risk factors have been identified for the development of SOS/VOD. Despite defibrotide is recommended for both prevention and treatment, there is no satisfactory therapy for managing severe SOS/VOD. In the present review we report the new definition for late onset SOS/VOD diagnosis and severity grading by the European Society for Blood and Marrow Transplantation, results of nationwide survey in Japan and current treatment.The Japan Society for Hematopoietic Stem Cell Transplantation, 2016, 日本造血細胞移植学会雑誌, 5(4) (4), 124 - 137, Japanese[Invited]Introduction scientific journal
- Nov. 2015, Bone Marrow Transplant, 50(11) (11), 1473 - 5, EnglishDynamic change of glycemic status during the early phase after allogeneic hematopoietic stem cell transplantation[Refereed]Report scientific journal
- Apr. 2015, Intensivist, 7(2号) (2号), 405 - 411, Japanese【ICUで遭遇する血液疾患】(Part 2.)血液内科のクリティカルシンドローム 造血幹細胞移植に伴う重症合併症(感染症を除く) 造血幹細胞移植に伴う類洞閉塞症候群/肝中心静脈閉塞症 深刻な合併症であり,予防法・治療法の確立が求められる[Refereed]Introduction commerce magazine
- 2015, Intern Med, 54(16) (16), 2057 - 60, EnglishRhabdomyolysis Caused by Candida parapsilosis in a Patient with Acute Myeloid Leukemia after Bone Marrow Transplantation[Refereed]Report scientific journal
- 2015, Intern Med, 54(22) (22), 2955, EnglishLow Hypodiploid Acute Lymphoblastic Leukemia with Burkitt-like Morphology[Refereed]Report scientific journal
- Nov. 2014, 臨床血液, 55(11号) (11号), 2339, Japanese腹部DLBCL病変出現1ヵ月前に発症したNeurolymphomatosisの1例Meeting report
- Mar. 2014, 皮膚の科学, 12(2) (2), 143, JapaneseSenile angiomaに腫瘍細胞の浸潤をみたintravascular large B-cell lymphomaの1例Meeting report
- May 2013, 頭頸部癌, 39(2号) (2号), 264, Japanese鼻腔原発NK/T細胞リンパ腫に対する放射線治療経験Meeting report
- Sep. 2012, Leuk Res, 36(9) (9), e202 - 5, EnglishCryptic insertion of BCL2 gene into immunoglobulin heavy locus in follicular lymphoma with t(6;9)(p23;p13)[Refereed]Report scientific journal
- 2012, Intern Med, 51(12) (12), 1579 - 84, EnglishIsolated isochromosome 17q in myelodysplastic syndromes with pure red cell aplasia and basophilia[Refereed]Introduction scientific journal
- Nov. 2011, 腫瘍内科, 8巻, 5号, pp. 505-513, Japanese【進化するがん免疫療法(ワクチン療法、細胞療法、抗体療法)】 抗体療法 造血器腫瘍の抗体療法Introduction scientific journal
- Jun. 2011, 内科, 107巻, 6号, pp. 1351-1354, Japanese【内科診療における論点】 血液 急性リンパ性白血病に対する骨髄非破壊的移植前治療を用いた同種造血幹細胞移植の適応をどう考えるか?Introduction scientific journal
- Others, 南江堂, 2018, Japanese新臨床腫瘍学 がん薬物療法専門医のために / 電解質異常(高カルシウム血症、低ナトリウム血症)Textbook
- Others, 南江堂, 2015, Japanese電解質異常(高カルシウム血症、低ナトリウム血症) / 新臨床腫瘍学 がん薬物療法専門医のためにTextbook
- Others, 南江堂, Mar. 2013, Japaneseがん薬物療法の支持療法マニュアル 〜症状の見分け方から治療まで〜 / がん薬物療法の支持療法マニュアル ?症状の見分け方から治療まで?General book
- Others, 南江堂, Dec. 2012, Japanese新臨床腫瘍学 がん薬物療法専門医のために / 電解質異常(高カルシウム血症、低ナトリウム血症)Textbook
- Others, 2012, Japanese電解質異常(高カルシウム血症、低ナトリウム血症) / 新臨床腫瘍学 がん薬物療法専門医のためにScholarly book
- Joint work, 医学書院, Jun. 2010, Japaneseがん診療レジデントマニュアル 第5版 / 造血幹細胞移植Textbook
- 第41回日本造血細胞移植学会総会, Mar. 2019, Japanese, 日本造血細胞移植学会, 大阪, Domestic conference筋炎症状で発症した節外性NK/T細胞リンパ腫Poster presentation
- 第41回日本造血細胞移植学会総会, Mar. 2019, Japanese, 日本造血細胞移植学会, 大阪, Domestic conferenceポナチニブ投与後に遅発性類洞閉塞症候群を発症した一例Poster presentation
- 第223回日本内科学会近畿地方会, Mar. 2019, Japanese, 日本内科学会, 京都, Domestic conferenceステロイド軟膏の使用中止後に相対的副腎不全をきたした1例Oral presentation
- 第223回日本内科学会近畿地方会, Mar. 2019, Japanese, 日本内科学会, 京都, Domestic conferenceEBV関連 sequential lymphomaの1例Oral presentation
- 米国血液学会, Dec. 2018, English, San Diego, International conferenceWould Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation?Poster presentation
- 第110回近畿血液学地方会, Nov. 2018, Japanese, 日本血液学会, 奈良, Domestic conferencePET/MRI陰性だが頭部造影MRIにて中枢神経浸潤が明らかとなった精巣原発DLBCLの一例Oral presentation
- APBMT, Nov. 2018, English, アジア太平洋骨髄移植学会, Taipei, International conferenceNutrition and Rehabilitation of Hematopoietic Stem Cell Transplantation PatientsPoster presentation
- 第80回日本血液学会学術集会, Oct. 2018, Japanese, 日本血液学会, 大阪, Domestic conference多発性筋炎様症状を呈したNK/T細胞リンパ腫Poster presentation
- 第80回日本血液学会学術集会, Oct. 2018, Japanese, 日本血液学会, 大阪, Domestic conference新たなZMYND11/MBTD1融合遺伝子の発現とt(10;17)(p15;q21)転座を認めたCD7+CD56+急性骨髄性白血病Poster presentation
- 第80回日本血液学会学術集会, Oct. 2018, Japanese, 日本血液学会, 大阪, Domestic conferenceシクロスポリン療法後の骨髄移植にて重症肝類洞閉塞症候群をきたした一例Poster presentation
- 第80回日本血液学会学術集会, Oct. 2018, Japanese, 日本血液学会, 大阪, Domestic conferenceTLR9の一塩基多型により無症候性CMV感染症を呈した再生不良性貧血の一例.Poster presentation
- 第80回日本血液学会学術集会, Oct. 2018, English, 日本血液学会, 大阪, Domestic conferenceDiscontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive actute myeloid leukemia.Poster presentation
- 第80回日本血液学会学術集会, Oct. 2018, Japanese, 日本血液学会, 大阪, Domestic conferenceCLLとの鑑別を要したt(18;22)(q21;q11)を伴う白血化で発症した濾胞性リンパ腫Poster presentation
- 第80回日本血液学会学術集会, Oct. 2018, English, 日本血液学会, 大阪, Domestic conferenceAplastic anemia that developed asymptomatic CMV infection due to a single nucleotide polymorphism of TLR9Poster presentation
- 第16回日本臨床腫瘍学会, Jul. 2018, English, 日本臨床腫瘍学会, 神戸, Domestic conferenceSynchronous esophageal cancer and multiple myeloma: a report of two casesPoster presentation
- 第40回日本造血細胞移植学会総会, Feb. 2018, Japanese, 日本造血細胞移植学会, 札幌, Domestic conference類洞閉塞症候群(SOS/VOD)のリスクファクター、検査・早期診断および治療 ー新ガイドラインの解説も含めた最近の潮流ーPublic discourse
- 第40回日本造血細胞移植学会総会, Feb. 2018, Japanese, 日本造血細胞移植学会, 札幌, Domestic conference非血縁者間骨髄移植前の病勢コントロールとしてGCD療法が有効であった肝脾原発T細胞性リンパ腫の一例Poster presentation
- 第40回日本造血細胞移植学会総会, Feb. 2018, Japanese, 日本造血細胞移植学会, 札幌, Domestic conferenceInvestigation of patients who required intensive care during the course of allo-HSCTOral presentation
- 第40回日本造血細胞移植学会総会, Feb. 2018, Japanese, 日本造血細胞移植学会, 札幌, Domestic conferenceA retrospective analysis of Pharmaceutical Inquiries in the Transplantation UnitOral presentation
- 第40回日本造血細胞移植学会総会, Feb. 2018, Japanese, 日本造血細胞移植学会, 札幌, Domestic conference自家末梢血幹細胞移植における栄養状態と予後に関する方視的解析Poster presentation
- 第40回日本造血細胞移植学会総会, Feb. 2018, Japanese, 日本造血細胞移植学会, 札幌, Domestic conference血縁ドナーにおける血液成分分離装置Spectra OptiaとCOBE Spectraの採取データの比較検討Poster presentation
- ASBMT/CIBMTR tandem meetings 2018, Feb. 2018, English, ASBMT/CIBMTR, Salt Lake City, USA, International conferencePharmacokinetics of intravenous mycophenolate mofetil after hematopoietic stem cell transplantation in Japanese populationPoster presentation
- 第40回日本造血細胞移植学会総会, Feb. 2018, Japanese, 日本造血細胞移植学会, 札幌, Domestic conferencePharmacokinetics of intravenous mycophenolate mofetil after cord blood transplantation in JapaneseOral presentation
- 第79回日本血液学会学術集会, Oct. 2017, Japanese, 日本血液学会, 東京, Domestic conferenceRetrospective analysis of TLS risk in lymphoma patients stratified by cholinesterase levelPoster presentation
- 第79回日本血液学会学術集会, Oct. 2017, English, 日本血液学会, 東京, Domestic conferenceRetrospective analysis of the ESHAP regimen for malignant lymphoma in Kobe University Hospital.Poster presentation
- The 79th annual meeting of the Japanese Society of Hematology, Oct. 2017, Japanese, Japanese Society of Hematology, 東京, Domestic conferenceMYC amplification in the form of ring chromosomes 8 in acute myeloid leukemia with t(11;16)(q13;p11)Poster presentation
- 第15回日本臨床腫瘍学会学術集会, Jul. 2017, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conferenceEstablishment and Gene Expression Analysis of a Double-Hit Lymphoma Cell LinePoster presentation
- 第107回近畿血液学地方会, Jun. 2017, Japanese, 日本血液学会, 京都, Domestic conference慢性C型肝炎治療後に発症したB細胞性前リンパ球性白血病の一例Oral presentation
- 第31回ヘルペスウイルス研究会, Jun. 2017, Japanese, 第31回ヘルペスウイルス研究会, 松江, Domestic conference造血幹細胞移植後のT細胞におけるCD134(OX40)の発現が、移植後HHV-6B再活性化および増殖の誘因となるOral presentation
- 兵庫県皮膚科医会 第116回総会・学術集談会, Jun. 2017, Japanese, 兵庫県皮膚科医会, 神戸, Domestic conferenceメトトレキサート関連リンパ増殖性疾患により生じた下腿潰瘍の一例Oral presentation
- Annual Meeting of the American Association for Cancer Research 2017, Apr. 2017, English, American Asociation for Cancer Research, Washington DC, USA, International conferenceMicroRNA-7 suppresses RB1 expression leading to chromosomal instability in leukemia cells harboring c-Kit mutationPoster presentation
- The 39th Annual Meeting of the Japan Socitey for Hematopoietic Cell Transplantation, Mar. 2017, Japanese, The Japan Society for Hematopoietic Cell Transplantation, 島根, Domestic conferenceA Case of Refractory Chronic GVHD of Lips Successfully Treated with Wrap TherapyPoster presentation
- 第39回日本造血細胞移植学会総会, Mar. 2017, Japanese, 日本造血細胞移植学会, 松江, Domestic conference肝中心静脈閉塞症(VOD)モデルマウスを用いた肝静脈閉塞への好中球細胞外トラップ(NETs)関与の可能性Oral presentation
- The 39th Annual Meeting of the Japan Socitey for Hematopoietic Cell Transplantation, Mar. 2017, Japanese, The Japan Society for Hematopoietic Cell Transplantation, 島根, Domestic conferenceDefibrotide and Thrombomodulin Treatment for Late Onset Sinusoidal Obstruction Syndrome after allo-HSCTOral presentation
- 第39回日本造血細胞移植学会総会, Mar. 2017, Japanese, 日本造血細胞移植学会, 松江, Domestic conferenceEffective immunosuppressive therapy with cyclosporine-A against relapsed pri mary cutaneous gamma/delta T-cell lymphoma after auto-PBSCTPoster presentation
- The 78th Annual Meeting of the Japanese Society of Hematology, Oct. 2016, Japanese, The Japanese Society of Hematology, 横浜, Domestic conferenceEarly Initiation of Defibrotide or Thrombomodulin Treatment for Sinusoidal Obstruction SyndromeOral presentation
- The 78th Annual Meeting of the Japanese Society of Hematology, Oct. 2016, Japanese, The Japanese Society of Hematology, 横浜, Domestic conference抗ARS抗体陽性間質性肺炎と甲状腺機能低下症に合併した後天性血友病APoster presentation
- The 78th Annual Meeting of the Japanese Society of Hematology, Oct. 2016, Japanese, The Japanese Society of Hematology, 横浜, Domestic conferenceThe antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimenPoster presentation
- The 78th Annual Meeting of the Japanese Society of Hematology, Oct. 2016, Japanese, The Japanese Society of Hematology, 横浜, Domestic conferenceConstitutional t(8;22)(q24;11.2) that mimics variant Burkitt-type translocation in Ph positive CMLPoster presentation
- 21st Congress of APBMT, Oct. 2016, English, Asia-Pacific Blood and Marrow Transplantation Group, Singapore, Singapore, International conferenceLONG-TERM FOLLOW-UP OUTPATIENT PROGRAM AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATIONOral presentation
- The 78th Annual Meeting of the Japanese Society of Hematology, Oct. 2016, Japanese, The Japanese Society of Hematology, 横浜, Domestic conferenceImpact of TBI on engraftment and non-relapse mortality in unrelated HCTOral presentation
- 21st Congress of APBMT, Oct. 2016, English, Asia-Pacific Blood and Marrow Transplantation Group, Singapore, Singapore, International conferenceEFFECTIVENESS OF THE HEMATOPOIETIC STEM CELL TRANSPLANTATION TEAM-BASED MEDICINE MEETINGS IN HYOGO PREFECTUREPoster presentation
- 第78回日本血液学会学術集会, Oct. 2016, Japanese, 一般社団法人 日本血液学会, 横浜, Domestic conferenceEarly initiation of defibrotide or thrombomodulin treatment for sinusoidal obstruction syndromeOral presentation
- 21st Congress of APBMT, Oct. 2016, English, Asia-Pacific Blood and Marrow Transplantation Group, Singapore, Singapore, International conferenceDEFIBROTIDE OR THROMBOMODULIN TREATMENT FOR SINUSOIDAL OBSTRUCTION SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN AND ADULTSPoster presentation
- 第78回日本血液学会学術集会, Oct. 2016, Japanese, 日本血液学会, 横浜市, Domestic conferenceCoexpression of NUP98/TOP1 and TOP1/NUP98 in de novo AML with t(11;20)(p15;q12) and t(2;5)(q33;q31)Poster presentation
- The 78th annual meeting of the japanese society of hematology, Oct. 2016, Japanese, Japanese Society of Hematology, 横浜, Domestic conferenceBRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia .Poster presentation
- The 21st Annual Congress of Asia Pacific Blood and Marrow Transplantation Group 2016, Oct. 2016, English, Asia-Pacific Blood and Marrow Transplantation Group, Singapore, Singapore, International conferenceA REDUCED INTENSITY CONDITIONING REGIMEN USING FLUDARABINE AND BUSULFAN (FLU-BU2)Poster presentation
- 第213回日本内科学会近畿地方会, Sep. 2016, Japanese, 日本内科学会, 大阪, Domestic conferenceリンパ節生検で完全梗塞が認められ診断に難渋したホジキンリンパ腫の1例Oral presentation
- 第14回日本臨床腫瘍学会学術集会, Jul. 2016, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conference発熱性好中球減少症における質量分析を用いた菌種同定の有用性についての検討Oral presentation
- 第14回日本臨床腫瘍学会学術集会, Jul. 2016, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conference同種造血幹細胞移植後のリンパ球回復と予後に関する後方視的解析Oral presentation
- 第14回日本臨床腫瘍学会, Jul. 2016, Japanese, 日本臨床腫瘍学会, 神戸市, Domestic conference造血器悪性腫瘍に対する化学療法中のD-indexと口腔内感染性合併症との関連についての検討Oral presentation
- 第14回日本臨床腫瘍学会学術集会, Jul. 2016, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conference急性骨髄性白血病に対するヘッジホッグ阻害薬投与の治療反応性バイオマーカーとしてのNANOG発現Oral presentation
- 第14回日本臨床腫瘍学会学術集会, Jul. 2016, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conference肝移植後のリンパ増殖性疾患に対する治療戦略Oral presentation
- 第14回日本臨床腫瘍学会学術集会, Jul. 2016, English, 日本臨床腫瘍学会, 神戸, Domestic conferenceTreatment strategies for double primary neoplasm patients who develop malignant lymphoma and solid tumorsOral presentation
- 第14回日本臨床腫瘍学会学術集会, Jul. 2016, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conferenceQuick detection of bacteria with mass spectrometry might reduce mortality in ferile neutropeniaOral presentation
- 第14回日本臨床腫瘍学会学術集会, Jul. 2016, Japanese, 日本臨床腫瘍学会, 神戸, Domestic conferenceMycophenolate Mofetilを使用した造血幹細胞移植後に発症したHHV-6脳炎の治療経過Oral presentation
- 7th, JSH International Symposium, May 2016, English, Japan Society of Hematology, Awaji, Japan, International conferenceDelayed Absolute Lymphocyte Count Recovery after Allogeneic Hematopoietic Stem Cell Transplantation with Mycophenolate MofetilPoster presentation
- 42nd, Annual Meeting of the European Society for Blood and Marrow Transplantation, Apr. 2016, English, European Society for Blood and Marrow Transplantation, Valencia, Spain, International conferenceNationwide Survey of Defbrotide and Recombinant Human Soluble Thrombomodulin for Treatment of Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell TransplantationOral presentation
- 42nd, Annual Meeting of the European Society for Blood and Marrow Transplantation, Apr. 2016, English, European Society for Blood and Marrow Transplantation, Valencia, Spain, International conferenceAbsolute Lymphocyte Count Recovery Predicts Clinical Outcome after Allogeneic Hematopoietic Stem Cell Transplantation in a Japanese PopulationPoster presentation
- 第38回日本造血幹細胞移植学会総会, Mar. 2016, Japanese, 日本造血細胞移植学会, 名古屋, Domestic conference自律神経ストームを伴った造血幹細胞移植後HHV-6脳炎Oral presentation
- 第31回日本静脈経腸栄養学会学術集会, Feb. 2016, Japanese, 福岡, Domestic conference造血幹細胞移植患者への栄養管理の前後比較Oral presentation
- 第19回日本病態栄養学会, Jan. 2016, Japanese, 日本静脈経腸栄養学会, 横浜, Domestic conference造血幹細胞移植患者への栄養管理の前後比較Oral presentation
- 第31回日本静脈経腸栄養学会, Jan. 2016, Japanese, 日本静脈経腸栄養学会, 横浜, Domestic conference造血幹細胞移植患者へのNEST介入前後の栄養評価Oral presentation
- 第19回日本病態栄養学会年次学術集会, Jan. 2016, Japanese, 日本病態栄養学会, 横浜, Domestic conference造血幹細胞移植患者へのNEST介入前後の栄養評価Oral presentation
- 第210回日本内科学会近畿地方, Nov. 2015, Japanese, 日本内科学会, 神戸, Domestic conference超高齢で発症した発作性夜間血色素尿症の1例。Oral presentation
- 第210回日本内科学会近畿地方, Nov. 2015, Japanese, 日本内科学会, 神戸, Domestic conference診断に難渋したhairy cell leukemiaの一例。Oral presentation
- 第20回アジア太平洋造血細胞移植学会年次学術集会, Oct. 2015, English, アジア太平洋造血細胞移植学会, 沖縄, International conferenceRetrospective Analysis of 384 Patients Diagnosed with Sinusoidal Obstruction Syndrome (SOS) who were not Treated with Defibrotide or Thrombomodulin: Historical Control Data for Prospective Trials of New Investigational Drugs for SOS[Invited]Invited oral presentation
- 第20回アジア太平洋造血細胞移植学会年次学術集会, Oct. 2015, English, アジア太平洋造血細胞移植学会, 沖縄, International conferencePhysical Functioning and Quality of Life of Patients Who Underwent Hematopoietic Stem Cell Transplantation: Impact of the Supports Provided at the Long-term Follow-up UnitOral presentation
- 第77回日本血液学会学術集会, Oct. 2015, English, 日本血液学会, 金沢, Domestic conferenceMixed phenotype acute leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and der(1;18)(q10;q10)Poster presentation
- 第20回アジア太平洋造血細胞移植学会年次学術集会, Oct. 2015, English, アジア太平洋造血細胞移植学会, 沖縄, International conferenceHerpesvirus 6 Encephalitis after Hematopoietic Stem Cell Transplantation with Administration of Mycophenolate Mofetil for Graft-versus-host Disease Prophylaxis in Japan: a Single Institution Experience.Poster presentation
- 第77回日本血液学会学術集会, Oct. 2015, English, 日本血液学会, 金沢, Domestic conferenceA case of scopulariopsis pneumonia with acute myeloid leukemiaPoster presentation
- 第77回日本血液学会学術集会, Oct. 2015, English, 日本血液学会, 金沢, Domestic conferenceA case of myeloid sarcoma with myelofibrosis secondary to polycthemia veraPoster presentation
- 第7回日本静脈経腸栄養学会近畿支部学術集会, Jul. 2015, Japanese, 京都, Domestic conference造血幹細胞移植患者へのNST介入の評価Oral presentation
- 第13回日本臨床腫瘍学会学術集会, Jul. 2015, English, 日本臨床腫瘍学会, 札幌, Domestic conferenceA phase 1b study of panobinostat and 5-azacitidine in Japanese patients with MDS, CMML, or AMLOral presentation
- the 6th JSH International Symposium, May 2015, English, 日本血液学会, 軽井沢, Domestic conferenceAbsolute Lymphocyte Count Recovery Predicts Clinical Outcomes after Allogeneic Hematopoietic Stem Cell TransplantationPoster presentation
- 第112回日本内科学会総会, Apr. 2015, Japanese, 日本内科学会, 京都, Domestic conference化学療法中の固形腫瘍患者に対するインフルエンザワクチン2回接種法の有効性と安全性.Oral presentation
- 日本薬学会第135年会, Mar. 2015, Japanese, 日本薬学会, 神戸, Domestic conference造血幹細胞移植患者に対する栄養管理への介入とその評価Poster presentation
- 第38回日本造血幹細胞移植学会総会, Mar. 2015, Japanese, 日本造血細胞移植学会, 名古屋, Domestic conference骨髄非破壊的造血幹細胞移植後の非感染性心内膜炎Oral presentation
- The 37th Annual Meeting of the Japan Society for Hematoloietic Cell Transplantation, Mar. 2015, English, 日本造血細胞移植学会, 神戸, Domestic conferenceNonbacterial thrombotic endocarditis after reduced-intensity conditioning for stem cell transplantationOral presentation
- 第207回近畿地方会, Mar. 2015, Japanese, 日本内科学会, 大阪, Domestic conference胃がんに対する胃切除を含め積極的治療介入が奏功した高齢者血管内リンパ腫Poster presentation
- 日本臨床腫瘍薬学会学術大会2015, Mar. 2015, Japanese, 日本臨床腫瘍薬学会, 京都, Domestic conference『抗がん薬の安全な取り扱いと曝露対策に関するプロジェクト』の取り組み-散剤調剤時の曝露状況について-Oral presentation
- 第54回 神戸血液病研究会, Feb. 2015, Japanese, 神戸血液病研究会, 神戸, Domestic conference急性骨髄性白血病に対して同種骨髄移植後にCandida Parapsilosis による横紋筋融解症を呈した1例Oral presentation
- 56th Meeting of the American Society of Hematology, Dec. 2014, English, American Society of Hematology, サンフランシスコ, International conferenceEfficacy of the Two-Dose Influenza Vaccine in Cancer Patients Receiving Chemotherapy: A Prospective Study.Poster presentation
- The 76th Annual Meeting, the Japanese Society of Hematology, Nov. 2014, English, Japanese Society of Hematology, 大阪, Domestic conferenceRapid recovery of lymphocyte counts after stopping MTX treatment might predict following regression of MTX-LPD.Poster presentation
- 第76回日本血液学会学術集会, Oct. 2014, English, 日本血液学会, 大阪, Domestic conferenceMYC amplification in the form of double minute chromosomes in two cases of acute myeloid leukemia.Poster presentation
- 第76回日本血液学会学術集会, Oct. 2014, English, 日本血液学会, 大阪, Domestic conferenceA case of spontaneous hemophilia B diagnoses in adulthoodPoster presentation
- 第201回日本内科学会近畿地方会, Sep. 2014, Japanese, 日本内科学会, 京都, Domestic conference骨髄異形成症候群に結核性多発膿瘍を併発した1例。Oral presentation
- 第52回日本癌治療学会学術集会, Aug. 2014, Japanese, 日本癌治療学会, 横浜, Domestic conference当院における『抗がん薬の安全な取り扱いと曝露対策に関するプロジェクト』の取り組みPoster presentation
- 第12回日本臨床腫瘍学会学術集会, Jul. 2014, Japanese, 日本臨床腫瘍学会, 福岡, Domestic conference当院における『抗がん薬の安全な取り扱いと曝露対策に関するプロジェクト』の取り組み-散薬服用時の曝露状況について-Oral presentation
- The 12th Annual Meeting of Japanese Society of Medical Oncology, Jul. 2014, Japanese, Japanese Society of Medical Oncology, 福岡, Domestic conference気道狭窄を伴う異なる頸部悪性腫瘍の2例Poster presentation
- The 12th Annual Meeting of Japanese Society of Medical Oncology, Jul. 2014, Japanese, Japanese Society of Medical Oncology, 福岡, Domestic conferenceA prospective study of the efficacy of influenza vaccination for cancer patients receiving chemotherapyOral presentation
- 第307回公益社団法人日本医学放射線学会関西地方会(第379回レントゲンアーベント), Jun. 2014, Japanese, 公益社団法人日本医学放射線学会関西地方会, 大阪, Domestic conference当院におけるゼヴァリンの初期経験Oral presentation
- EHA, Jun. 2014, English, EHA, ミラノ, イタリア, International conferencePoor Prognosis of Patients with Severe Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation in Japanese population: On Behalf of Complications Working Group of the Japan Society for Hematopoietic Cell Transplantation (JPoster presentation
- 第36回日本造血細胞移植学会総会, Mar. 2014, English, 日本造血細胞移植学会, 沖縄, Domestic conference同種造血幹細胞移植後の類洞閉塞症候群の発症割合、リスク因子ならびに治療法に関する研究Oral presentation
- ASH, Dec. 2013, English, American Society of Hematology, New Orleans, USA, International conferenceNationwide Survey of Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Outcome: On Behalf of Complications Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCPoster presentation
- 55th ASH Annual Meeting and Exposition, Dec. 2013, English, American Society of Hematology, New Orleans, USA, International conferenceGvhd Prophylaxis With Mycophenolate Mofetil and Clacineurin Inhibitor In Allogeneic Hematopoietic Cell Transplantation From HLA-Matche SibligsOr 7-8/8HLA-Matched Unrelated Volunteer Donors;A Japanese,Multicenter,Phase II TrialOral presentation
- 第75回日本血液学会学術集会, Oct. 2013, Japanese, 日本血液学会, 札幌, Domestic conferenceResults of a retrospective study about MTX-LPD and a puestionnaire 'How I treat MTX-LPD'Poster presentation
- 第75回日本血液学会学術集会, Oct. 2013, Japanese, 日本血液学会, 札幌, Domestic conferenceExtramedullary T-lymphoid crisis of ETV6/ABL1-positive myeloproliferative neoplasm with t(7;14)Poster presentation
- 第75回日本血液学会学術集会, Oct. 2013, English, 日本血液学会, 札幌, Domestic conferenceA case of primary cardiac intermediate Burkitt / Diffuse large B cell lymphomaPoster presentation
- 第37回日本頭頸部癌学会, Jun. 2013, Japanese, 日本頭頸部癌学会, 新宿、東京(京王プラザホテル), Domestic conference鼻腔原発NK/T細胞リンパ腫に対する放射線治療経験Poster presentation
- The 17th meeting of Asia Pacific Blood and Marrow Transplantation Group, Oct. 2012, English, Asia Pacific Blood and Marrow Transplantation Group, India, Tolvaptan as an alternative treatment for refractory fluid retention associated with sinusoidal obstruction syndrome after allogeneic stem cell transplantation, International conferenceTolvaptan as an alternative treatment for refractory fluid retention associated with sinusoidal obstruction syndrome after allogeneic stem cell transplantationPoster presentation
- The 17th meeting of Asia Pacific Blood and Marrow Transplantation Group, Oct. 2012, English, Asia Pacific Blood and Marrow Transplantation Group, India, Retrospective analysis of safety and efficacy of (R-) LEED and (R-) MCEC regimens followed by autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma., International conferenceRetrospective analysis of safety and efficacy of (R-) LEED and (R-) MCEC regimens followed by autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.Poster presentation
- The 17th meeting of Asia Pacific Blood and Marrow Transplantation Group, Oct. 2012, English, Asia Pacific Blood and Marrow Transplantation Group, India, Candica parapsilosis as a cause for rhabdomyolysis in a patient with acute myeloid leukemia after bone marrow transplantation., International conferenceCandica parapsilosis as a cause for rhabdomyolysis in a patient with acute myeloid leukemia after bone marrow transplantation.Poster presentation
- The 74th Annual meeting of the Japaneses society of Hematology, Oct. 2012, Japanese, Japaneses society of Hematology, 京都, Domestic conferenceA novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34)Poster presentation
- 第10回日本臨床腫瘍学会学術集会, Jul. 2012, Japanese, 日本臨床腫瘍学会, 大阪, cancer related VTEの現状, Domestic conference当科における悪性腫瘍に伴う静脈血栓塞栓症(VTE)の検討Poster presentation
- 第10回日本臨床腫瘍学会学術集会, Jul. 2012, Japanese, 日本臨床腫瘍学会, 大阪, 当科においける静脈血栓塞栓症(VTE) 症例の検討, Domestic conference当科においける静脈血栓塞栓症(VTE) 症例の検討Poster presentation
- 第10回日本臨床腫瘍学会学術集会, Jul. 2012, Japanese, 日本臨床腫瘍学会, 大阪, 切除不能神経内分泌腫瘍に対するダカルバジン単剤療法:後方視的解析, Domestic conference切除不能神経内分泌腫瘍に対するダカルバジン単剤療法:後方視的解析Poster presentation
- 第74回日本血液学会学術集会, Jun. 2012, English, 日本血液学会, 京都, Domestic conferenceSecondary Phiradelphia-positive mixed-phenotype acute leukemia after adjuvant chemotherapy with S-1.Poster presentation
- 38th Annual Meeting of the European Group for Blood and Marrow Transplantation, Apr. 2012, English, European Group for Blood and Marrow Transplantation, Geneva, Switzerland, International conferenceHyperglycaemia during the early phase after haematopoietic stem cell transplantation is caused by the elevation of insulin resistancePoster presentation
- 第41回日本皮膚アレルギー・接触皮膚炎学会総会・学術大会, Jul. 2011, Japanese, 日本皮膚アレルギー・接触皮膚炎学会, 山梨, Domestic conference皮疹を欠くもののHHV-6の再活性化と様々な症状発現を伴い、レクチゾールによるDIHS様変化を呈した1例Oral presentation
- 第33回日本造血細胞移植学会総会, Mar. 2011, Japanese, 日本造血細胞移植学会, 松山, Domestic conferenceSuccessful treatment with intravitreal injection of voricanazole in a patient with fungal endophthalmitis before cord blood transplantationPoster presentation
- 第33回日本造血細胞移植学会総会, Mar. 2011, Japanese, 日本造血細胞移植学会, 愛媛, Domestic conferenceChanges in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantaiton:results of elderly patientsOral presentation
- 第33回日本造血細胞移植学会総会, Mar. 2011, Japanese, 日本造血細胞移植学会, 愛媛, Domestic conferenceChanges in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantaiton:results of younger patientsPoster presentation
- 第33回日本造血細胞移植学会総会, Mar. 2011, Japanese, 日本造血細胞移植学会, 松山, Domestic conferenceOptimal use of G-CSF after allogeneic hematopoietic stem cell transplantation under MMF dosing for GVHD prophylaxisPoster presentation
- BMT Tandem meetings, Feb. 2011, English, 米国骨髄移植学会, ホノルル, 米国, International conferenceDay +11 Methotrexate (MTX) might Reduce the Risk of Engraftment Syndrome (ES) and Acute Graftversus-Host Disease (GVHD) after Unrelated Bone Marrow Transplantation (U-BMT) with Reduced-Intensity Conditioning RegimensPoster presentation
- 第52回米国血液学会, Dec. 2010, English, 米国血液学会, オーランド, 米国, International conferenceEngraftment Syndrome (ES) After Reduced-Intensity Stem Cell Transplantation (RIST): ES May Have a Negative Impact on Survival In Standard-Risk PatientsPoster presentation
- 第52回米国血液学会, Dec. 2010, English, 米国血液学会, オーランド, 米国, International conferenceComparison of Outcomes After Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) In 73 Patients with Follicular Lymphoma (FL), Transformed Follicular Lymphoma (TL), or De Novo Diffuse Large B-Cell Lymphoma (DLBCL): Favorable Outcome for TL Similar toPoster presentation
- 第52回米国血液学会, Dec. 2010, English, 米国血液学会, オーランド, 米国, International conferenceChanges In Incidence and Causes of Non-Relapse Mortality (NRM) After Allogeneic Hematopoietic Cell Transplantation (allo-HCT): Are Transplants Improving?Oral presentation
- 第94回近畿血液学地方会, Nov. 2010, Japanese, 近畿血液学地方会, 大津, Domestic conferenceMTX関連リンパ腫の2例Oral presentation
- 第72回日本血液学会総会, Sep. 2010, Japanese, 日本血液学会, 横浜, Domestic conferenceフル移植とミニ移植の比較Others
- 第72回日本血液学会総会, Sep. 2010, Japanese, 日本血液学会, 横浜, Domestic conferenceTherapy-related pure erythroid leukemia with hemophagocytic syndromePoster presentation
- 第72回日本血液学会総会, Sep. 2010, Japanese, 日本血液学会, 横浜, Domestic conferenceRecent changes in non-relapse mortality after allogeneic hematopoietic cell transplantationOral presentation
- 第72回日本血液学会総会, Sep. 2010, Japanese, 日本血液学会, 横浜, Domestic conferenceEngraftment syndrome after reduced-intensity stem cell transplantationOral presentation
- 第72回日本血液学会総会, Sep. 2010, Japanese, 日本血液学会, 横浜, Domestic conferenceA novel dicentric chromosome, dic(9;9)(p12;q34), in follicular lymphoma withaut t(14;18)Poster presentation
- 第31回日本造血細胞移植学会総会, Feb. 2009, Japanese, 日本造血細胞移植学会, 札幌, Domestic conference造血幹細胞移植後の類洞閉塞症候群に対するデフィブロタイドの有効性の検討Oral presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferenceSequential measurement of portal flow is helpful for assessment of SOS treatment with defibrotidePoster presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferenceEffectiveness of cord blood transplant for adult acute lymphoblastic leukemia in CRPoster presentation
- 第70回日本血液学会総会, Oct. 2008, Japanese, 日本血液学会, 京都, Domestic conferencePure red cell aplasia with primary screlosing cholangitis improved after liver transplantationPoster presentation